These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827 [TBL] [Abstract][Full Text] [Related]
30. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators. Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185 [TBL] [Abstract][Full Text] [Related]
31. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure. Echouffo-Tcheugui JB; Masoudi FA; Bao H; Curtis JP; Heidenreich PA; Fonarow GC Eur J Heart Fail; 2019 Sep; 21(9):1093-1102. PubMed ID: 31359595 [TBL] [Abstract][Full Text] [Related]
32. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT). Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576 [TBL] [Abstract][Full Text] [Related]
33. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
35. The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies. Chung ES; Gold MR; Abraham WT; Young JB; Linde C; Anderson C; Lu X; Ikuemonisan JO; Fagan DH; Tsintzos SI; Rickard J Heart Rhythm; 2022 Apr; 19(4):595-603. PubMed ID: 34843964 [TBL] [Abstract][Full Text] [Related]
36. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy. Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940 [TBL] [Abstract][Full Text] [Related]
37. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309 [TBL] [Abstract][Full Text] [Related]
38. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M; Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135 [TBL] [Abstract][Full Text] [Related]
39. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease. Friedman DJ; Singh JP; Curtis JP; Tang WHW; Bao H; Spatz ES; Hernandez AF; Patel UD; Al-Khatib SM J Am Coll Cardiol; 2015 Dec; 66(23):2618-2629. PubMed ID: 26670062 [TBL] [Abstract][Full Text] [Related]
40. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT JACC Heart Fail; 2017 Mar; 5(3):204-212. PubMed ID: 28254126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]